| __timestamp | Ascendis Pharma A/S | Johnson & Johnson |
|---|---|---|
| Wednesday, January 1, 2014 | 6274000 | 21954000000 |
| Thursday, January 1, 2015 | 9415000 | 21203000000 |
| Friday, January 1, 2016 | 11504000 | 19945000000 |
| Sunday, January 1, 2017 | 13482000 | 21420000000 |
| Monday, January 1, 2018 | 25057000 | 22540000000 |
| Tuesday, January 1, 2019 | 48473000 | 22178000000 |
| Wednesday, January 1, 2020 | 76669000 | 22084000000 |
| Friday, January 1, 2021 | 160180000 | 20118000000 |
| Saturday, January 1, 2022 | 221227000 | 19046000000 |
| Sunday, January 1, 2023 | 264410000 | 20112000000 |
| Monday, January 1, 2024 | 284545000 | 21969000000 |
Unveiling the hidden dimensions of data
In the competitive world of pharmaceuticals, managing Selling, General, and Administrative (SG&A) expenses is crucial for profitability. Johnson & Johnson, a stalwart in the industry, has consistently maintained its SG&A expenses around $20 billion annually from 2014 to 2023. In contrast, Ascendis Pharma A/S, a rising star, has seen its SG&A costs grow from $6 million in 2014 to $264 million in 2023, reflecting its rapid expansion.
Over the past decade, Johnson & Johnson's SG&A expenses have shown a slight decline, indicating efficient cost management despite its vast scale. Meanwhile, Ascendis Pharma's expenses have surged by over 4,000%, highlighting its aggressive growth strategy. This comparison underscores the different financial strategies employed by established giants and emerging innovators in the pharmaceutical sector.
Johnson & Johnson and Merck & Co., Inc.: SG&A Spending Patterns Compared
Operational Costs Compared: SG&A Analysis of Johnson & Johnson and Amgen Inc.
Breaking Down SG&A Expenses: Johnson & Johnson vs Alnylam Pharmaceuticals, Inc.
Johnson & Johnson and BioMarin Pharmaceutical Inc.: SG&A Spending Patterns Compared
SG&A Efficiency Analysis: Comparing Johnson & Johnson and Exelixis, Inc.
Who Optimizes SG&A Costs Better? Johnson & Johnson or Jazz Pharmaceuticals plc
Who Optimizes SG&A Costs Better? Dr. Reddy's Laboratories Limited or Ascendis Pharma A/S
Ascendis Pharma A/S and Lantheus Holdings, Inc.: SG&A Spending Patterns Compared
Ascendis Pharma A/S or Xenon Pharmaceuticals Inc.: Who Manages SG&A Costs Better?
SG&A Efficiency Analysis: Comparing Ascendis Pharma A/S and PTC Therapeutics, Inc.
Who Optimizes SG&A Costs Better? Ascendis Pharma A/S or Galapagos NV
Ascendis Pharma A/S or Evotec SE: Who Manages SG&A Costs Better?